PF-Atlas › Clinical Trials › NCT05259046
The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health
Menaquinone-7 tablet · Not specified
Registry ID
NCT05259046
Phase
Not specified
Status
Active, not recruiting
Drug / intervention
Menaquinone-7 (MK-7) tablet (333 µg)
Sponsor
Bispebjerg Hospital
Start
2022-06-21
Enrollment
450
Locations
1
About this trial
The purpose of this study is to examine the effect of menaquinone-7 (MK-7) supplementation on cardiovascular, metabolic, and bone health.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT05259046 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.